Persistence Market Research

Intra-Operative Imaging Market Revenue Predicted to Go Up by 2015 to 2021

Intra-operative imaging is used to localize and target the diseased tissue and to monitor and control the treatment.


New York, NY -- (SBWIRE) -- 12/09/2016 -- Imaging is essential for the detection and monitoring of disease for the treatment. Intra-operative imaging is mainly used during cranial surgeries, as it helps to take images during the surgery without making the patient move, and helps continue with the surgery depending upon the new information. Intra-operative imaging is used to localize and target the diseased tissue and to monitor and control the treatment. Magnetic resonance imaging, ultra-sound based systems, and computed tomography (CT) are mainly used the intra-operative imaging modalities. Intra-operative magnetic resonance imaging is used to create images of the brain during majority of cranial surgeries. It helps create an accurate image of the brain, in order to remove brain tumor and other abnormalities directly, safely, and effectively during the surgery. In addition, it also helps to locate abnormalities if the brain has shifted during the surgery and distinguish abnormal brain tissues from normal brain tissues. It is mainly used during surgery such as brain tumor, dystonia, epilepsy, pituitary tumor, Parkinson's disease, neuropsychiatric disorders, essential tremors, pediatric brain tumor, and glioma. Surgery proceeds in a normal manner with standard instruments and techniques. Intra-operative imaging, during surgery, enables neuro-surgeons to operate more precisely. Moreover, it reduces the need for the patient to undergo a second surgery and also reduces the risk of surgical complication. Sometimes, this technology is also used in combination with neuro-navigation system, to navigate the brain during the surgery, without damaging the vital areas of the brain. In addition, surgical image, with the help of intra-operative imaging devices, has shaped the future of surgical procedure by improving the sensitivity and accuracy of surgeries.

North America dominates the global market for intra-operative imaging due to increasing government investments, research activities, and growing number of collaborations between various players in the region. Asia is expected to grow at a high rate in the next five years in the global intra-operative imaging market, with China and India being the fastest-growing markets in the Asia Pacific region. The key driving forces for the intra-operative imaging market in developing countries are the large pool of patients, improving health care infrastructure, rising health care awareness, increasing health care expenditure, growing number of research projects, and rising government funding for research activities in the region.

Rising need for accuracy in surgeries, increasing number of tumor and cancer cases, technological advancements, increasing number of surgeries, and rise in government funding and investment are fueling the growth of the global intra-operative imaging market. In addition, increasing demand for high end automated imaging devices and increasing need for highly sophisticated imaging technologies, increasing health care expenditure, improving health care infrastructure in the developing countries, and increase in health care awareness are some of the key factors driving the growth of the global intra-operative imaging market. However, strict regulations for procedure, risk and complications associated with surgeries, and lack of trained and skilled researchers, act as major restraints for the growth of the global intra-operative imaging market.

Request for Sample Report and Table of content @

Automation in cancer research for early cancer detection would pose an opportunity for the global intra-operative imaging market. Rising collaborations and partnerships between various companies is an ongoing trend in the global intra-operative imaging market. The major companies operating in the global intra-operative imaging market are Philips Healthcare, Siemens Healthcare, Brainlab AG, Medtronic plc, NeuroLogica Corporation, Imaging3, Inc., and IMRIS Inc.